Therapy Areas: Oncology
Epic Sciences elects Richard J. Wenstrup, MD as CMO
23 April 2019 -

Epic Sciences Inc, a developer of novel diagnostics to personalise and advance the treatment and management of cancer, disclosed on Monday the addition of Richard J. Wenstrup, MD as its chief medical officer.

In the medical department, Dr Wenstrup will lead the company's clinical development, oversee its regulatory and medical affairs strategies as well as be responsible for advancing its clinical research and product development pipeline.

Dr Wenstrup has served in a variety of clinical leadership roles managing life science companies over the past 25 years. He was the chief medical officer for Oxford Immunotec Inc and Myriad Genetics before that.

Previously, Dr Wenstrup was a tenured professor of paediatrics in human genetics at Cincinnati Children's Hospital Medical Center as well as in biomedical engineering at the University of Cincinnati.

Also, Dr Wenstrup was the founding director of the Molecular Diagnostics Laboratory at Cincinnati Children's Hospital as well as a co-founder of Assurex Health Inc.

Login
Username:

Password: